布普伦诺啡因诱导策略的最佳实践
Jessica L Skarda1, Rachel M Sasser, Ashley D Johnson
1Jessica L. Skarda, Rachel M. Sasser, Ashley D. Johnson, and Susanne A. Fogger, School of Nursing, University of Alabama at Birmingham, Birmingham, Alabama.
Journal of addictions nursing
|November 18, 2025
概括
对阿片类药物使用障碍的布普伦诺芬诱导与芬太尼具有挑战性. 使用低剂量的布普伦诺芬和重叠的阿片类激动症的新协议可以改善治疗参与度并减少戒断症状.
科学领域:
- 成 药物 药物 药物 药物
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 在美国,阿片类药物过量仍然是一个关键的公共卫生问题.
- 布普伦诺芬显著降低了阿片类药物使用障碍 (OUD) 的死亡率.
- 像芬太尼这样的高强度合成阿片类药物复杂化了布普伦诺芬的诱导并增加了戒断.
研究的目的:
- 评估布普伦诺芬诱导的最佳实践.
- 开发一个以证据为基础的协议,以提高诱导成功.
- 为了应对芬太尼和戒断症状带来的挑战.
主要方法:
- 使用了Define-Measure-Analyze-Design-Verify和CDC的程序性评估框架.
- 进行了回顾性图表分析 (n=21) 和专注的文献综述.
- 开发了一个标准化的协议,用于低剂量布普伦诺芬诱导与重叠的阿片类药物激动症.
主要成果:
- 戒断症状是停止治疗的主要原因 (n=6).
- 只有42%的患者记录了临床阿片类药物戒断量表 (COWS) 的得分,阻碍了评估.
- 开发的协议旨在标准化评估和改善诱导结果.
结论:
- 标准化的退出评估,特别是使用COWS尺度,至关重要.
- 低剂量布普伦诺芬诱导协议与重叠的阿片类药物激动症可以减轻戒断.
- 需要基于证据的协议来优化OUD的布普伦诺芬治疗参与和保留.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
892
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
892
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
224
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
224
Depolarizing Blockers: Pharmocokinetics
554
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
554
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
208
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
208
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K


